A recent filing from ETF Managers Group outlines plans for the firm to launch an ETF that will target the medical marijuana and industrial hemp industries. The Emerging AgroSphere ETF is currently set to become the first of its kind as there have been no other similar ETF filings.
The prospectus indicates that the fund’s underlying index will track companies that engage in research on cannabidiol CBD and cannabis derivatives and synthetics for use in prescription drugs and in companies that produce or sell derivatives of industrial hemp. The index can also include companies that are involved in the supply chains of the two previously mentioned types of companies.
The document clearly states that the component companies’ involvement with marijuana must be entirely lawful, but it does also note that could change if marijuana usage becomes legal for nonmedical purposes.
The index provider relies on publicly available sources to determine which companies qualify for inclusion in the index. Companies can be selected from U.S. and foreign markets but must meet size and liquidity requirements and be listed in a market that meets investability requirements.
According to the prospectus, the index is rebalanced and reconstituted on a quarterly basis.
The filing did not include an expense ratio or ticker, but it did indicate the fund will list on the NYSE Arca.
Contact Heather Bell at [email protected].